These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10471919)

  • 1. Nuclear medicine finds the right chemistry.
    Sattelberger AP; Atcher RW
    Nat Biotechnol; 1999 Sep; 17(9):849-50. PubMed ID: 10471919
    [No Abstract]   [Full Text] [Related]  

  • 2. 99m-Technetium carbohydrate conjugates as potential agents in molecular imaging.
    Bowen ML; Orvig C
    Chem Commun (Camb); 2008 Nov; (41):5077-91. PubMed ID: 18956031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the reference source method to determine the half-lives of radionuclides of importance in nuclear medicine.
    da Silva MA; de Almeida MC; da Silva CJ; Delgado JU
    Appl Radiat Isot; 2004; 60(2-4):301-5. PubMed ID: 14987658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals.
    Tisato F; Bolzati C; Porchia M; Refosco F
    Mass Spectrom Rev; 2004; 23(5):309-32. PubMed ID: 15264232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A memoir of pediatric nuclear medicine: Part II: Challenges in the development of a subspecialty.
    J Nucl Med; 2006 May; 47(5):22N-24N, 26N, 28N passim. PubMed ID: 16736563
    [No Abstract]   [Full Text] [Related]  

  • 6. Nuclear medicine chemistry.
    Fowler J
    J Nucl Med; 2001 Jan; 42(1):14N. PubMed ID: 11197966
    [No Abstract]   [Full Text] [Related]  

  • 7. Postmeeting summary on the round table discussion at the Seventh International Symposium on Technetium in Chemistry and Nuclear Medicine held in Bressanone, Italy on Sept 6-9, 2006.
    Eckelman WC; Erba PA; Schwaiger M; Wagner HN; Alberto R; Mazzi U
    Nucl Med Biol; 2007 Jan; 34(1):1-4. PubMed ID: 17210456
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship between elution time and eluate volume using the Ultra-TechneKow DTE technetium-99m generator.
    Hung JC; Mahoney DW; Huang DC; Wang A
    J Nucl Med Technol; 2000 Sep; 28(3):178-81. PubMed ID: 11001502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A defining moment: Nuclear medicine, molecular imaging, SNM.
    Sandler MP
    J Nucl Med; 2006 Jul; 47(7):36N, 37N. PubMed ID: 16871699
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibody therapies in transfusion medicine.
    Ouwehand WH; Watkins NA; Garner SF; Smethurst PA
    Vox Sang; 2004 Jul; 87 Suppl 2():151-4. PubMed ID: 15209903
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethical, green and sustainable nuclear medicine.
    Perkins AC
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):979-81. PubMed ID: 23632961
    [No Abstract]   [Full Text] [Related]  

  • 12. Microwave-assisted synthesis of 3,1,2- and 2,1,8-Re(I) and 99mTc(I)-metallocarborane complexes.
    Green AE; Causey PW; Louie AS; Armstrong AF; Harrington LE; Valliant JF
    Inorg Chem; 2006 Jul; 45(15):5727-9. PubMed ID: 16841972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hand exposure to ionising radiation of nuclear medicine workers.
    Wrzesień M; Olszewski J; Jankowski J
    Radiat Prot Dosimetry; 2008; 130(3):325-30. PubMed ID: 18310609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of chimeric monoclonal antibodies by genetically manipulated chickens.
    Kamihira M; Kawabe Y; Shindo T; Ono K; Esaka K; Yamashita T; Nishijima K; Iijima S
    J Biotechnol; 2009 Apr; 141(1-2):18-25. PubMed ID: 19428726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic interventions in nuclear medicine assessment of cardiac perfusion.
    Matte GG; Barnes DC; Abrams DN
    J Pharm Pharm Sci; 2001; 4(3):255-62. PubMed ID: 11737992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control of 99Mo/99Tcm generators: results of a survey of the Radiopharmacy Working Group of the Italian Association of Nuclear Medicine (AIMN).
    Marengo M; Aprile C; Bagnara C; Bolzati C; Bonada C; Candini G; Casati R; Civollani S; Colombo FR; Compagnone G; Del Dottore F; Di Guglielmo E; Ferretti PP; Lazzari S; Minoia C; Pancaldi D; Ronchi A; Sanità di Toppi G; Saponaro R; Torregiani T; Uccelli L; Vecchi F; Piffanelli A
    Nucl Med Commun; 1999 Nov; 20(11):1077-84. PubMed ID: 10572919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the origin of the N-terminal pyro-glutamate variation in monoclonal antibodies using model peptides.
    Dick LW; Kim C; Qiu D; Cheng KC
    Biotechnol Bioeng; 2007 Jun; 97(3):544-53. PubMed ID: 17099914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex.
    Waibel R; Alberto R; Willuda J; Finnern R; Schibli R; Stichelberger A; Egli A; Abram U; Mach JP; Plückthun A; Schubiger PA
    Nat Biotechnol; 1999 Sep; 17(9):897-901. PubMed ID: 10471933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationization of monoclonal antibodies: another step towards the "magic bullet"?
    Vaisitti T; Deaglio S; Malavasi F
    J Biol Regul Homeost Agents; 2005; 19(3-4):105-12. PubMed ID: 16602624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput LC/MS methodology for a(1-->3)Gal determination of recombinant monoclonal antibodies: a case study.
    Huang L; Mitchell CE
    Methods Mol Biol; 2005; 308():411-9. PubMed ID: 16082052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.